ARQT FY 2022 Earnings — Arcutis Biotherapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ARQTArcutis Biotherapeutics, Inc.

$3B

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M

Gross Profit

$3M79.5% margin

Operating Income

-$302M-8183.0% margin

Net Income

-$311M-8449.8% margin

EPS (Diluted)

$-5.66

Cash Flow

Operating Cash Flow

-$258M

Free Cash Flow

-$281M

Stock-Based Comp.

$33M

Balance Sheet

Total Assets

$449M

Total Liabilities

$240M

Stockholders' Equity

$210M

Cash & Equivalents

$54M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$0	—
Gross Profit	$3M	-$763,000	+484.3%
Operating Income	-$302M	-$207M	-46.0%
Net Income	-$311M	-$206M	-50.9%